Beyond time to expand the use of adaptive servo-ventilation
Abstract
Extract Numerous patients should benefit from the European Respiratory Society (ERS) and European Sleep Research Society (ESRS) position [1] that it is fine to use adaptive servo-ventilation (ASV) in patients whose left ventricular ejection fraction (LVEF) is at least 30%. The American Academy of Sleep Medicine (AASM) also recently endorsed using ASV to treat central sleep apnoea in patients with heart failure [2]. This is exactly what we recommended in 2016 [3] in response to AASM guidelines [4] to not use ASV in patients with primarily central sleep apnoea with LVEF below 45%.
Fields of Study & Subjects
Obstructive Sleep Apnea Research
Respiratory Support and Mechanisms
Neuroscience of respiration and sleep
Publication details
- Journal / source
- European Respiratory Journal
- Volume
- 67
- Issue
- 3
- Pages
- 2502013–2502013
- Publication date
- 1 March 2026
- Language
- EN